RATIONALE: Behavioral consequences of convulsive episodes are well documented, but less attention was paid to changes that occur in response to subconvulsant doses of drugs. OBJECTIVES: We investigated short- and long-term effects of a single systemic injection of a subconvulsant dose of pilocarpine on the behavior of rats as evaluated in the elevated plus maze. METHODS AND RESULTS: Pilocarpine induced an anxiogenic-like profile 24 h later, and this effect persisted for up to 3 months (% of time spent on open arms at 24 h, control = 35.47 ± 3.23; pilocarpine 150 = 8.2 ± 2.6; 3 months, control = 31.9 ± 5.5; pilocarpine 150 = 9.3 ± 4.9). Temporary inactivation of fimbria-fornix with lidocaine 4% promoted an anxiolytic-like effect per se, suggesting a tonic control of this pathway on the modulation of anxiety-related behaviors. Lidocaine also reduced the anxiogenic-like profile of animals tested 1 month after pilocarpine treatment (% of time spent on open arms, saline + phosphate-buffered saline (PBS) = 31.7 + 3.7; saline + lidocaine = 54.4 + 4.7; pilocarpine + PBS = 10.3 + 4.1; pilocarpine + lidocaine = 40.1 + 9.1). To determine whether the anxiogenic-like effect was mediated by septal region or by direct hippocampal projections to the diencephalon, the neural transmission of post-commissural fornix was blocked, and a similar reduction in the anxiogenic-like effect of pilocarpine was observed. CONCLUSIONS: Our findings suggest that a single systemic injection of pilocarpine may induce long-lasting anxiogenic-like behavior in rats, an effect that appears to be mediated, in part, through a direct path from hippocampus to medial hypothalamic sites involved in fear responses.
RATIONALE: Behavioral consequences of convulsive episodes are well documented, but less attention was paid to changes that occur in response to subconvulsant doses of drugs. OBJECTIVES: We investigated short- and long-term effects of a single systemic injection of a subconvulsant dose of pilocarpine on the behavior of rats as evaluated in the elevated plus maze. METHODS AND RESULTS:Pilocarpine induced an anxiogenic-like profile 24 h later, and this effect persisted for up to 3 months (% of time spent on open arms at 24 h, control = 35.47 ± 3.23; pilocarpine 150 = 8.2 ± 2.6; 3 months, control = 31.9 ± 5.5; pilocarpine 150 = 9.3 ± 4.9). Temporary inactivation of fimbria-fornix with lidocaine 4% promoted an anxiolytic-like effect per se, suggesting a tonic control of this pathway on the modulation of anxiety-related behaviors. Lidocaine also reduced the anxiogenic-like profile of animals tested 1 month after pilocarpine treatment (% of time spent on open arms, saline + phosphate-buffered saline (PBS) = 31.7 + 3.7; saline + lidocaine = 54.4 + 4.7; pilocarpine + PBS = 10.3 + 4.1; pilocarpine + lidocaine = 40.1 + 9.1). To determine whether the anxiogenic-like effect was mediated by septal region or by direct hippocampal projections to the diencephalon, the neural transmission of post-commissural fornix was blocked, and a similar reduction in the anxiogenic-like effect of pilocarpine was observed. CONCLUSIONS: Our findings suggest that a single systemic injection of pilocarpine may induce long-lasting anxiogenic-like behavior in rats, an effect that appears to be mediated, in part, through a direct path from hippocampus to medial hypothalamic sites involved in fear responses.
Authors: Patrícia A M Guidine; Gustavo H S Rezende; Cláudio M T Queiroz; Luiz Eugênio Mello; Vânia F Prado; Marco A M Prado; Grace S Pereira; Márcio F D Moraes Journal: Neurosci Lett Date: 2008-03-13 Impact factor: 3.046
Authors: Demitry Kazlouski; Michael D H Rollin; Jason Tregellas; Megan E Shott; Leah M Jappe; Jennifer O Hagman; Tamara Pryor; Tony T Yang; Guido K W Frank Journal: Psychiatry Res Date: 2011-04-17 Impact factor: 3.222
Authors: Filipe S Duarte; Marcelo Duzzioni; Alexandre A Hoeller; Nayana M Silva; Andy L Ern; Tetsade C Piermartiri; Carla I Tasca; Elaine C Gavioli; Tadeu Lemos; Antonio P Carobrez; Thereza C M De Lima Journal: Psychopharmacology (Berl) Date: 2012-12-29 Impact factor: 4.530
Authors: Alexandre A Hoeller; Ana Paula R Costa; Maíra A Bicca; Filipe C Matheus; Gilliard Lach; Francesca Spiga; Stafford L Lightman; Roger Walz; Graham L Collingridge; Zuner A Bortolotto; Thereza C M de Lima Journal: PLoS One Date: 2016-01-21 Impact factor: 3.240